• Careers
  • News and Events
  • Investors
  • PAREXEL Japan
  •  
Locate a Pharmaceutical Consulting Partner
Pharmaceutical Development Library
PAREXEL Career Center

CNS capabilities

Unparalleled Early Phase CNS Leadership

PAREXEL's early phase clinical experts are equipped with the knowledge to deliver a wide range of services and techniques in-house for psychiatric and neurological studies of varying complexity, with an emphasis in acute psychiatric and sleep disorders. Our experience conducting studies involving patients with Parkinson’s and Alzheimer’s disease, schizophrenia and major depressive orders, is second to none.

Our team specializes in the performance of:

  • Pain modeling
  • Proof of Concept testing
  • Bio- and surrogate marker evaluations
  • Inpatient acute psychiatric therapies
  • Pharmacokinetic/pharmacodynamic characterizations
  • Continuous cerebrospinal fluid collection (Dynabridging)
  • Polysomnography

Our clinical leaders utilize various tools in achieving high quality results, including:

  • Positron-Emitting Tomography (PET)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Quantitative EEG
  • Evoked potential techniques

About PAREXEL Early Phase

With a full scope of services from First in Man through Proof of Concept, PAREXEL Early Phase has a global network of clinical units that test compounds and devices in healthy volunteers and patients, helping our biopharmaceutical clients make valuable decisions quickly and safely.